BGI Genomics and Healthlink were among the investors that added an undisclosed sum to the $10m in series B funding Congenica raised in February.
UK-based clinical genomics software developer Congenica has closed a series B round of undisclosed size after securing additional funding from investors including genomics technology provider BGI Genomics and healthcare services provider Healthlink.
Investment platform Future Planet Capital was also among the new investors, adding to the £8m ($10m) first tranche, which closed in February this year with backing from Cambridge Innovation Capital (CIC), Amadeus Capital Partners and Parkwalk Advisors.
Congenica has built a software platform called Sapientia that analyses data…
